Patents and Trade Regulations


The objectives of WG3 are to ascertain how trade regulations and policy may impact medicine procurement

(including bilateral or individual contracts, protection of commercial interests).

Key research questions:

1. How are patterns of national and regional pharmaceutical production and supply affected by the TRIPS agreement, Doha Declaration and international standards for pharmaceutical production?

2. What is the impact of other international regulations (such as the procurement decisions made by international agencies and bilateral trade agreements)?